Monitoring renal function during combination therapy with telaprevir in HIV/HCV co-infected patients with advanced/fibrosis cirrhosis

INTRODUCTION: Telaprevir (TVR) plus peg interferon (PEG-IFN) and ribavirin (RBV) substantially increase treatment efficacy for genotype 1 chronic hepatitis C virus (HCV) infection but data about its safety in HIV patients with cirrhosis are lacking. Our purpose was to evaluate estimated Glomerular F...

Descripción completa

Detalles Bibliográficos
Autores principales: Puzzolante, Cinzia, Vecchia, Marco, Zona, Stefano, Borghi, Vanni, Guaraldi, Giovanni, Mussini, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P095
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224941/
https://www.ncbi.nlm.nih.gov/pubmed/25394131
http://dx.doi.org/10.7448/IAS.17.4.19627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224941/
https://www.ncbi.nlm.nih.gov/pubmed/25394131
http://dx.doi.org/10.7448/IAS.17.4.19627

Ejemplares similares